- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/26 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 237/26
Total number of patents in this class: 146
10-year publication summary
|
8
|
7
|
16
|
7
|
5
|
7
|
7
|
9
|
10
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Tagworks Pharmaceuticals B.V. | 50 |
9 |
| Merck Patent GmbH | 5815 |
6 |
| President and Fellows of Harvard College | 5986 |
5 |
| Rigel Pharmaceuticals, Inc. | 538 |
5 |
| Hallura Ltd. | 12 |
5 |
| The Regents of the University of California | 19961 |
3 |
| Bayer AG | 3325 |
3 |
| Abbvie Inc. | 1800 |
3 |
| Mirati Therapeutics, Inc. | 252 |
3 |
| Vanderbilt University | 1907 |
3 |
| Transthera Sciences (nanjing), Inc. | 71 |
3 |
| F. Hoffmann-La Roche AG | 7947 |
2 |
| LG Chem, Ltd. | 17635 |
2 |
| Merck Sharp & Dohme Corp. | 2191 |
2 |
| Boehringer Ingelheim Vetmedica GmbH | 1273 |
2 |
| Centre National de La Recherche Scientifique | 10464 |
2 |
| Monsanto Technology LLC | 8317 |
2 |
| Northwestern University | 3398 |
2 |
| Illumina, Inc. | 3353 |
2 |
| Tohoku University | 2792 |
2 |
| Other owners | 80 |